Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MICRO-VERZ: MICRObiome Changes During VERZenio Therapy

NCT07406594 is registered in ClinicalTrials.gov with University of Vermont Medical Center as lead sponsor.

NCT NCT07406594
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07406594 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MICRO-VERZ: MICRObiome Changes During VERZenio Therapy
Lead sponsor
University of Vermont Medical Center
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 31, 2027
Completion date
October 31, 2031
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, her-2 positive breast cancer